NCT03233711 2026-03-18
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
9 trialsNCT07472868 2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3 Not yet recruiting
NCT05976763 2026-03-04
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT00486512 2020-09-03
Chemoprevention of Colorectal Adenomas
Colotech A/S
Phase 3 Terminated
NCT00883792 2017-06-19
NordICC
Oslo University Hospital
Phase 3 Active not recruiting
NCT01075633 2014-01-08
COLONFAM
Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Phase 3 Completed
NCT01937429 2013-09-09
GRAND BLEU
Hospices Civils de Lyon
Phase 3 Unknown
NCT01251666 2012-09-03
HeMO
University Hospital, Caen
Phase 3 Completed
NCT01399710 2011-07-22
CAD-IMPACT
im3D S.p.A.
Phase 3 Completed